| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Larimar Therapeutics, Inc. (LRMR) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. LRMR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 9.54M | $37.87M | - | |
| Dir | 664.8K | $2.64M | - | |
| Dir | 19.0K | $75.4K | - | |
| Dir | 19.0K | $75.4K | - | |
| Dir | 19.0K | $75.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 24, 2015 | Starr Kevin P | Director | Sell | 136,579 | $43.90 | $5,995,402.77 | -22.1% | |
| Sep 18, 2015 | Goldberg Avi Y. | Director | Sell | 5,000 | $45.00 | $225,000.00 | -8.5% | |
| Sep 18, 2015 | Hughes Thomas E. | Chief Executive Officer | Sale+OE | 45,626 | $42.53 | $1,940,670.00 | -96.5% | |
| Sep 17, 2015 | Secor Alicia | Chief Commercial Officer | Sale+OE | 26,256 | $41.05 | $1,077,808.80 | -95.4% | |
| Sep 17, 2015 | Kim Dennis D | Chief Medical Officer | Sale+OE | 39,407 | $40.00 | $1,576,280.00 | -100% | |
| Sep 14, 2015 | Kim Dennis D | Chief Medical Officer | Sale+OE | 593 | $40.00 | $23,720.00 | -100% | |
| Jun 10, 2015 | Goldberg Avi Y. | Director | Sell | 3,000 | $35.00 | $105,000.00 | -4.9% | |
| Jun 1, 2015 | Goldberg Avi Y. | Director | Sell | 2,000 | $32.23 | $64,452.40 | -3.1% |